No Data
No Data
Express News | Aligos Therapeutics Strengthens Senior Leadership Team With the Appointment of Hardean Achneck, Md as Chief Medical Officer
Press Release: Aligos Therapeutics Strengthens Senior Leadership Team With the Appointment of Hardean Achneck, MD as Chief Medical Officer
Aligos Therapeutics Analyst Ratings
H.C. Wainwright Maintains Aligos Therapeutics(ALGS.US) With Buy Rating, Maintains Target Price $75
Aligos Therapeutics Shares Are Trading Lower. The Company Announced Results From Its Phase 2a HERALD Study.
Aligos Therapeutics' ALG-055009 Trial Met Primary Goal In MASH; In Talks For Fund; Stock Drops
No Data
No Data